Arkolith/Insider Trading/OLMA/Form 4

Kovacs Shane William Charles

CH. OPERATING & FINANCIAL OFF.Olema Pharmaceuticals, Inc. (OLMA) · full profile →Form 4 · filed Jan 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.0M
Net Open-Market Flow
-$3.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 15, 2026Sell(S)100K$28.73$2.9M140K
Jan 13, 2026Sell(S)4K$28.01$107K240K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001579397-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML